AI assistant
Sending…
Zymeworks Inc. — Director's Dealing 2022
Dec 24, 2022
32180_dirs_2022-12-23_278aad5a-72c8-45c3-af0c-f0ada3d2b2ff.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Zymeworks Inc. (ZYME)
CIK: 0001937653
Period of Report: 2022-12-21
Reporting Person: RENTON HOLLINGS (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-12-21 | Stock Option (Right to Buy) | $8.75 | A | 25000 | Acquired | 2032-12-20 | Common Stock (25000) | Direct |
Footnotes
F1: Stock options vest on date of next annual general meeting following grant date of December 21, 2022.